Cooper Companies | COO - Frais De Vente Et D'Administration

Prix De L'Action
64.41
Variation Quotidienne
-0.54 -0.83%
Mensuellement
-9.85%
Annuel
-20.37%
Q2 Prévisions
68.52




Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Align Technology USD 441.68M 23.88M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Bausch Health Companies USD 801M 6M 2025-12
Baxter International USD 761M 53M 2025-12
Bayer EUR 4.05B 647M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dentsply International USD 383M 28M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Novartis USD 3.44B 132M 2025-12
ResMed USD 278.4M 19.2M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Utah Medical Products USD 2.61M 741K 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12